Section 7-3213 - Office of Opioid Abatement(a)(1) There is established within the Department of Behavioral Health the Office of Opioid Abatement.(2) The Office shall be led by a Director with at least 10 years' professional experience and education in prevention, recovery, treatment, and harm reduction efforts for opioid use disorder and co-occurring substance use and mental health disorders.(b) The Office shall have the power and duty to: (1) Conduct a District-wide needs assessment to identify structural gaps and needs related to opioid use disorder and co-occurring substance use and mental health disorders;(2) Support the Commission's activities by providing staffing, research and policy expertise, facilities, technical assistance, and other resources;(3) Assist the Commission in preparing its recommendations regarding goals, objectives, and performance indicators pursuant to section 102(h)(2)(A); (4) Integrate the work of the Office and Commission and Fund expenditures with existing District strategic planning related to opioid use disorder and co-occurring substance use and mental health disorders;(5) Develop governing principles, policies, and procedures for the application and awarding of monies and grants from the Fund;(6) Oversee expenditures from the Fund, including by preparing a quarterly accounting of expenditures from the Fund and the Fund balance;(7) Issue, manage, and oversee awards and grants from the Fund, including collecting and publicly reporting data from awardees and grantees concerning the effectiveness of infrastructure, activities, practices, programs, services, supports, and strategies funded;(8) Prepare the annual report required by section 5012(f) of the Opioid Abatement Fund Establishment Act of 2022, effective September 21, 2022 (D.C. Law 24-167; D.C. Official Code § 1-325.441(f)) ; and(9) Create and maintain a public website that includes: (A) Commission meeting attendance, agendas, and minutes;(B) The governing principles, policies, and procedures developed pursuant to paragraph (5) of this subsection;(C) The quarterly accountings of Fund expenditures and Fund balance prepared pursuant to paragraph (6) of this subsection;(D) A listing of awards and grants from the Fund and awardee and grantee data collected pursuant to paragraph (7) of this subsection; and(E) The annual reports prepared pursuant to section 5012(f) of the Opioid Abatement Fund Establishment Act of 2022, effective September 21, 2022 (D.C. Law 24-167; D.C. Official Code § 1-325.441(f)) .(c)(1) If the Office decides not to follow a Commission recommendation in whole or in part, the Office shall provide the Commission with a written explanation for its decision within 14 days after the decision is made.(2) The Commission shall have at least 7 days after receipt of the Office's written explanation provided pursuant to paragraph (1) of this subsection to provide a written response before the Office proceeds with its decision.Added by D.C. Law 24-315, § I-103 , 70 DCR 000838, eff. 3/10/2023.